title: Immunotherapy synergizes with chemotherapy targeting pancreatic cancer.
authors.forename: Shigeo
authors.initials: S
authors.lastname: Koido
authors.forename: Sadamu
authors.initials: S
authors.lastname: Homma
authors.forename: Akitaka
authors.initials: A
authors.lastname: Takahara
authors.forename: Yoshihisa
authors.initials: Y
authors.lastname: Namiki
authors.forename: Hideo
authors.initials: H
authors.lastname: Komita
authors.forename: Kan
authors.initials: K
authors.lastname: Uchiyama
authors.forename: Masaki
authors.initials: M
authors.lastname: Ito
authors.forename: Jianlin
authors.initials: J
authors.lastname: Gong
authors.forename: Toshifumi
authors.initials: T
authors.lastname: Ohkusa
authors.forename: Hisao
authors.initials: H
authors.lastname: Tajiri
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D011379:Prognosis; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D019496:Cancer Vaccines